Yazar "Bilgihan, Kamil" için listeleme
-
Conventional corneal collagen cross-linking versus transepithelial diluted alcohol and iontophoresis-assisted corneal cross-linking in progressive keratoconus
Bilgihan, Kamil; Yeşilırmak, Nilufer; Altay, Yeşim; Yuvarlak, Armağan; Özdemir, Hüseyin Baran (Lippincott Williams & Wilkins, 2017)Purpose: To compare clinical outcomes of conventional corneal cross-linking (C-CXL) and diluted alcohol and iontophoresis-assisted corneal cross-linking (DAI-CXL) for the treatment of progressive keratoconus (KC). Methods: ... -
Evaluation of Long-Term Corneal Morphology After Photorefractive Keratectomy by In Vivo Confocal Microscopy and Specular Microscopy; 20-Year Follow-Up
Bilgihan, Kamil; Yesilirmak, Nilufer; Altay, Yesim; Tefon, Atike B.; Ozdemir, Huseyin B.; Ozdogan, Sibel; Gurelik, Gokhan (Lippincott Williams & Wilkins, 2019)Purpose: To evaluate long-term corneal morphological changes after photorefractive keratectomy (PRK) using in vivo confocal microscopy (IVCM) and specular microscopy. Methods: This comparative case-control study included ... -
Iontophoresis Corneal Cross-linking With Oxygen Supplementation in Ovine Eyes
Aribas, Yavuz Kemal; Aribas, Atike Burcin Tefon; Ercin, Ugur; Sarikaya, Burcu; Bilgihan, Ayse; Bilgihan, Kamil (Slack Inc, 2022)PURPOSE: To evaluate the biomechanical changes and ad-vanced oxidation protein products (AOPP) production after different corneal cross-linking (CXL) protocols with or with-out oxygen supplementation.METHODS: Ovine eyes ... -
Pregnancy-induced progression of keratoconus
Purpose: To report eyes with keratoconus that progressed during pregnancy. Methods: Seven eyes of 4 patients with progression of keratoconus during pregnancy were included in this study. The mean age of patients and ... -
Singlet oxygen formation during accelerated and hyperaccelerated corneal cross-linking: in vitro study
Erçin, Uğur; Arıbaş, Yavuz Kemal; Arıbaş, Atike Burçin Tefon; Bilgihan, Kamil; Bilgihan, Ayşe (2021)BACKGROUND: To evaluate the singlet oxygen (1 O2) production of oxygen assisted %0.1 riboflavin and ultraviolet-A (UVA) crosslinking therapy (with and without oxygen assistance), in combination with standard, accelerated ...